Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics.

Slides:



Advertisements
Similar presentations
CZ5225 Methods in Computational Biology Lecture 9: Pharmacogenetics and individual variation of drug response CZ5225 Methods in Computational Biology.
Advertisements

Single Nucleotide Polymorphism And Association Studies Stat 115 Dec 12, 2006.
FDA Pharmacogenetic Labels A Clinical Perspective David A Flockhart MD, PhD Indiana University School of Medicine Clinical Pharmacology Subcommittee of.
Molecular Biology C SSheng Zhao ( 赵晟 ), Biochemistry and Molecular Department of Medical school in Southeast University CCouse QQ Club: (
Dr. Almut Nebel Dept. of Human Genetics University of the Witwatersrand Johannesburg South Africa Significance of SNPs for human disease.
Biochemical and Molecular Genetics of Human Disease I
Biology and Bioinformatics Gabor T. Marth Department of Biology, Boston College BI820 – Seminar in Quantitative and Computational Problems.
Computational Tools for Finding and Interpreting Genetic Variations Gabor T. Marth Department of Biology, Boston College
Pharmacogenomics in Drug Development FDA Science Board April 9, 2003 Brian B. Spear, Ph.D. Director, Pharmacogenomics Abbott Laboratories.
Human Genomic Variation The Story of SNPs. Single Nucleotide Polymorphisms (SNPs)  In addition to variation in microsatellites (VNTRs), genetic variation.
PHAR 751 Pharmacogenomics Sarah Brown, Pharm.D. Pharmacy Practice Resident Asante Health System
Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research.
Richard D. Hockett, Jr. M.D. Sr. Clinical Research Physician Group Leader, Genomic Medicine FDA Clinical Pharmacology Advisory Committee Integrating Pharmacogenomics.
Pharmacogenomics Eric Jorgenson.
Utilizing Science & Technology and Innovation for Development A Genome Wide Association Study for Type 2 Diabetes Susceptibility Gene and Treatment in.
The Accelerating Pace of Medical Development and Challenges in Evaluating Benefit and Risk Alasdair Breckenridge Medicines and Healthcare products Regulatory.
Computational research for medical discovery at Boston College Biology Gabor T. Marth Boston College Department of Biology
Pharmacogenetics and Pharmacogenomics Eric Jorgenson 2/24/9.
The medical relevance of genome variability Gabor T. Marth, D.Sc. Department of Biology, Boston College Medical Genomics Course – Debrecen,
Conservation of genomic segments (haplotypes): The “HapMap” n In populations, it appears the the linear order of alleles (“haplotype”) is conserved in.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
More than 90% compounds entering clinical trials fail to demonstrate safety and efficacy in human, despite evidence of safety and effectiveness in pre-
Interactions Eric Jorgenson EPI 217 2/22/11. Outline Gene-Environment Interaction Gene-Gene Interaction Pharmacogenetics Pharmacogenomics.
De la farmacogenética a la farmacogenómica Javier Benitez Programa Genética del Cáncer Humano Centro Nacional Investigaciones Oncológicas Madrid Junio.
Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation ZHU FENG Innovative Drug Research Centre.
Personalized Medicine Dr. M. Jawad Hassan. Personalized Medicine Human Genome and SNPs What is personalized medicine? Pharmacogenetics Case study – warfarin.
Lecture 6. Functional Genomics: DNA microarrays and re-sequencing individual genomes by hybridization.
In The Name of GOD Genetic Polymorphism M.Dianatpour MLD,PHD.
Integrating Pharmacogenomic Questions Into GCIG Ovarian Cancer Clinical Trials Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research.
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
Computational Biology and Genomics at Boston College Biology Gabor T. Marth Department of Biology, Boston College
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Pharmacogenomics: Improving the Dynamic of Care in Medication Management 1.
Origins of Pharmacogenomics. Archibald Garrod In 1902 Garrod characterized the condition of alcaptonuria as one resulting from an absence of the.
약물유전체학 Pharmacogenomics Kangwon National Univ School of Medicine Hee Jae Lee PhD.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
Pharmacogenetics/Pharmacogenomics. Outline Introduction  Differential drug efficacy  People react differently to drugs Why does drug response vary?
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Common variation, GWAS & PLINK
Nucleotide variation in the human genome
Common variants vs Rare variants
Pharmacogenomics: towards personalized medicine
The Evaluation of CYP2D6, CYP2C9 and CYP2C19 Polymorphisms for Personalized Medicine in Psychiatry Patients Ebru DÜNDAR YENILMEZ1, Onur KARAYTUG2, Lut.
Endogenous and exogenous factors contribute to variability in drug effects physiological pathological genetic Goodman and Gilman, 2011.
Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics.
David Daniel Rico Sarvenaz Zóltan.
The Evaluation of CYP2D6, CYP2C9 and CYP2C19 Polymorphisms for Personalized Medicine in Physiciatry Patients Ebru DUNDAR YENILMEZ1, Onur KARAYTUG2, Lut.
Enzymes involved in drug metabolism
Pharmacogenetic effects on pharmacokinetics and pharmacodynamics
Working Groups (thematic description)
Understanding the Basics of Pharmacology
Introduction to bioinformatics lecture 11 SNP by Ms.Shumaila Azam
Mahla sattarzadeh Kerman University of Medical Sciences
Biopharmaceutics Dr Mohammad Issa Saleh.
Genomic and therapy Anti-PCSK9 (evolocumab) for hypercolesteolemia
Pharmacogenomics in Inflammatory Bowel Disease
Beatriz Pérez González 2017/18 Genomics
Pharmacogenomics Genes and Drugs.
In these studies, expression levels are viewed as quantitative traits, and gene expression phenotypes are mapped to particular genomic loci by combining.
Exercise: Effect of the IL6R gene on IL-6R concentration
Pharmacogenetics and Pharmacoepidemiology “PHCY 480”
Clinical Pharmacokinetics
Medical genomics BI420 Department of Biology, Boston College
Genomic and therapy Anti-PCSK9 (evolocumab) for hypercolesteolemia
Medical genomics BI420 Department of Biology, Boston College
Introduction to Pharmacogenetics
The principles of genetic association
Presentation transcript:

Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics associate to a certain phenotype (specific therapeutic outcome) a certain genotype. The promise of pharmacogenomics is that by knowing the genotype in a patient it will be possible to predict the therapeutic outcome.

For some diseases the percentage of drug response is still unsatisfactory US Food and Drug Administration

Interindividual variability in drug response Treatment outcome (same dose) Response No effect Adverse effect                        

Exogenous and endogenous factors that contribute to interindividual variability in drug response Physiological Pathological Genetic Goodman and Gilman, 2011

Genetic characteristics predispose to the response to substances Pitagora (Samo?, 570 b.C. – Metaponto, 495 b.C.) He forbade his disciples to eat broad beans (for the risk of favism?). Lucrezio (Campania, 98 /96 b.C. – Roma 55 /53 b.C.) Quod ali cibus est aliis fuat acre venenum. What is food for a man, it is poison for another. «De rerum natura» Libro IV, linea 637 Pirmohamed, Br J Clin Pharmacol 2001 Ventura

Relling & Evans, Nature 2015

Modulation of the dose and drug effects Paracelso (Philip Theophrastus Bombastus von Hohenheim) (Einsiedeln 1493 – Salisburgo 1541) “Omnia venenum sunt: nec sine veneno quicquam existit. Dosis sola facit, ut venenum non fit” “All things are poison and nothing is without poison; only the dose makes a thing not a poison” Yip et al., Clin Pharm Ther 2015

History of pharmacogenetics and pharmacogenomics Pirmohamed, Br J Clin Pharmacol 2001

L’emivita dell’antipirina ha una concordanza maggiore nei gemelli identici che nei gemelli non identici. Vessel & Page, Science 1968 Goodman and Gilman, 2011

Exemple of pharmacogenetic trait Enzyme thiopurine- S-methyltransferase Thiopurine-S-methyltransferase enzymatic activity Stocco et al., Human Mol Genet 2012

Cheok & Evans, 2006

Cheok & Evans, 2006

Definitions of genetic terms Gene: fundamental unit, physical and functional, of heritability, that transmits biological information from a generation to the next. Phenotype: morphological and functional characteristic of an organism determined by its genotype and modulated by the environment. Genetic polymorphism: presence in the population of more variants of the same phenotype determined by different alleles with a frequency higher than 1%. Allele: alternative form of a specific gene.

How big is the genome? How many genes does it contain? http://jul2012.archive.ensembl.org/Homo_sapiens/Location/Genome?r=1:1-1000000

Objective of pharmacogenetic research To associate to a certain PHENOTYPE (therapetuic response, adverse effects, resistance) a particular GENOTYPE GENOTYPE Single Nucleotide Variants (SNPs) Deletions Repeated sequences Expression profiles (mRNA) PHENOTYPE Therapeutic response Adverse effects Lack of efficacy

Methods of pharmacogenetic research The most critical step is to define and measure the drug-response phenotype. Discovery model can be based on candidate gene studies or agnostic genome-wide analyses. Pharmacogenetic discoveries require independent validation before they can be translated into clinical diagnostics. The validation process can be facilitated by elucidating the mechanisms that determine how the variation alters drug responses. Relling & Evans, Nature 2015

From the molecular point of view, drug efficacy is related to the concentration of active spiecies at the site of action. Proteins that have a role in determining drugs: - PHARMACOKINETICS (absorpion, distribution, metabolism, elimination, transport) - PHARMACODYNAMICS (molecular targets) can influence therapeutic response.

some of the main enzymes involved in the metabolic inactivation of drugs present polymorphisms of activity that are genetically determined (Science 1999; 286: 487-491)